Study Stopped
COVID-19
Trans-abdominal Fetal Pulse Oximetry: Tissue Light Scattering
1 other identifier
observational
4
1 country
1
Brief Summary
This study is being conducted to study light scattering properties of maternal-fetal tissue.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2019
CompletedFirst Submitted
Initial submission to the registry
September 3, 2019
CompletedFirst Posted
Study publicly available on registry
September 9, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 20, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
June 8, 2021
CompletedAugust 11, 2021
August 1, 2021
1.9 years
September 3, 2019
August 9, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Optical signal from maternal and fetal tissues
The study of light scattering through maternal/fetal tissue and through maternal tissue alone and newborn tissue alone using a commercial frequency domain oximeter and 2nd generation prototype.
Peri-operative
Interventions
The ISS Device (commercial and prototype) is used to measure tissue light scattering.
Eligibility Criteria
Women with singleton pregnancies of 36 weeks gestation or more undergoing c-section.
You may qualify if:
- Pregnant women with singleton pregnancies, vertex or breech presentation, scheduled for non-emergent cesarean delivery, including cesarean delivery for failure to progress with reassuring electronic fetal heart rate tracing
- Age greater than or equal to 18 years of age.
- Healthy women at equal to or greater than 36 weeks gestation undergoing non-emergency cesarean delivery
- Spinal or epidural anesthesia
You may not qualify if:
- Emergency cesarian delivery
- Non-reassuring fetal heart rate tracing
- Less than 18 years of age
- Multiple gestation (twins, triplets)
- Presentation other than vertex or breech
- Less than 36 weeks of gestation
- General anesthesia
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Tufts Medical Center
Boston, Massachusetts, 02111, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 3, 2019
First Posted
September 9, 2019
Study Start
July 1, 2019
Primary Completion
May 20, 2021
Study Completion
June 8, 2021
Last Updated
August 11, 2021
Record last verified: 2021-08
Data Sharing
- IPD Sharing
- Will not share